Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-HIV1 Surface protein gp120 Nanobody (SAA0894) (RVV03105)

Host species:Alpaca
Isotype:VHH-8His-Cys-tag
Applications:ELISA
Expression system:Mammalian Cells
Overview

Catalog No.

RVV03105

Expression system

Mammalian Cells

Species reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) (HIV-1)

Host species

Alpaca

Isotype

VHH-8His-Cys-tag

Clonality

Monoclonal

Target

Envelope glycoprotein gp160, Env polyprotein, Surface protein gp120, SU, Glycoprotein 120, gp120, Transmembrane protein gp41, TM, Glycoprotein 41, gp41, env

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Purified by Nickel column.

Accession

P04578

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA0894

Data Image
  • SDS-PAGE
    SDS PAGE for HPV16 E7/Protein E7 Antibody
References

Plugging gp120s cavity. PMID: 19000812

Progress in targeting HIV-1 entry. PMID: 16182193

HIV-1--co-receptors binding. PMID: 9095160

Estimating the threshold surface density of Gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusion. PMID: 21647388

Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug. PMID: 21345545

HIV-1 gp120: A Target for Therapeutics and Vaccine Design. PMID: 26302793

Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition. PMID: 21636577

Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. PMID: 12960231

Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity. PMID: 28446609

GP120: target for neutralizing HIV-1 antibodies. PMID: 16551265

CD4 activation of HIV fusion. PMID: 1281202

Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120. PMID: 29463753

The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120. PMID: 26432362

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41. PMID: 26324044

Conformational properties of HIV-1 gp120/V3 immunogenic domains. PMID: 15974987

HIV-1 attachment: another look. PMID: 10217828

Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor. PMID: 34372601

Cell surface down-modulation of CD4 after infection by HIV-1. PMID: 8005387

[Sequence variation of HIV and bioinformatics]. PMID: 15449902

Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. PMID: 15591114

Structure and Dynamics of the Native HIV-1 Env Trimer. PMID: 25762739

Multiple binding modes of an N-terminal CCR5-peptide in complex with HIV-1 gp120. PMID: 34921512

HIV-1 gp120 and immune network. PMID: 15370273

Mechanisms of apoptosis induction by the HIV-1 envelope. PMID: 15719026

HIV-1 entry and its inhibition. PMID: 12932074

Gp120 binding with DC-SIGN induces reactivation of HIV-1 provirus via the NF-κB signaling pathway. PMID: 26837416

HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors. PMID: 12873765

Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist. PMID: 24502450

Sequence-conserved and antibody-accessible sites in the V1V2 domain of HIV-1 gp120 envelope protein. PMID: 25051095

Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface. PMID: 34586861

Stoichiometric parameters of HIV-1 entry. PMID: 25463598

Covalent conjugation of a peptide triazole to HIV-1 gp120 enables intramolecular binding site occupancy. PMID: 24801282

The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. PMID: 10873786

Specific binding of HIV-1 envelope protein gp120 to the structural membrane proteins ezrin and moesin. PMID: 9213396

Glycosylation of the ENV spike of primate immunodeficiency viruses and antibody neutralization. PMID: 15279588

Effect of HIV-1 Env on SERINC5 Antagonism. PMID: 27928004

The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding. PMID: 9704015

Redox control on the cell surface: implications for HIV-1 entry. PMID: 12626125

Intramolecular quality control: HIV-1 envelope gp160 signal-peptide cleavage as a functional folding checkpoint. PMID: 34469718

The SPL7013 dendrimer destabilizes the HIV-1 gp120-CD4 complex. PMID: 26495445

Caprine arthritis-encephalitis virus envelope surface glycoprotein regions interacting with the transmembrane glycoprotein: structural and functional parallels with human immunodeficiency virus type 1 gp120. PMID: 14557643

Virus entry as a target for anti-HIV intervention. PMID: 12871111

Probability of Immobilization on Host Cell Surface Regulates Viral Infectivity. PMID: 33016741

Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. PMID: 2234433

Molecular mechanism of HIV-1 gp120 mutations that reduce CD4 binding affinity. PMID: 23297802

Identification of a glycan cluster in gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate. PMID: 33057580

Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes. PMID: 7811011

HbAHP-25 attenuates HIV-1 gp120 mediated inflammation and barrier dysfunction. PMID: 29210152

HIV-1 entry inhibitors in the side pocket. PMID: 10555140

Coreceptors: implications for HIV pathogenesis and therapy. PMID: 9122710

From receptor recognition mechanisms to bioinspired mimetic antagonists in HIV-1/cell docking. PMID: 11334348

Use of the quartz crystal microbalance to monitor ligand-induced conformational rearrangements in HIV-1 envelope protein gp120. PMID: 20016882

gp120: Biologic aspects of structural features. PMID: 11244037

The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel. PMID: 26018158

A modeled structure of an aptamer-gp120 complex provides insight into the mechanism of HIV-1 neutralization. PMID: 20527993

Inhibition of HIV entry by carbohydrate-binding proteins. PMID: 16569440

Allosteric induction of the CD4-bound conformation of HIV-1 Gp120. PMID: 24304511

HIV gp120: double lock strategy foils host defences. PMID: 9739096

An anti-HIV-1 gp120 antibody expressed as an endocytotic transmembrane protein mediates internalization of HIV-1. PMID: 14592761

Molecular architecture of native HIV-1 gp120 trimers. PMID: 18668044

Characteristics of HIV-1 gp120 glycoprotein binding to glycolipids. PMID: 8021969

A study of the coevolutionary patterns operating within the env gene of the HIV-1 group M subtypes. PMID: 17921487

Autophagy and CD4+ T lymphocyte destruction by HIV-1. PMID: 17012832

Novel therapies based on mechanisms of HIV-1 cell entry. PMID: 12773651

A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein. PMID: 23696718

Retrocyclin, an antiretroviral theta-defensin, is a lectin. PMID: 12707350

HIV requires multiple gp120 molecules for CD4-mediated infection. PMID: 2374593

The role of the viral glycoprotein in HIV-1 persistence. PMID: 10065629

Antibody neutralization of human immunodeficiency virus type 1 (HIV-1). PMID: 12739253

Imaging of HIV-1 envelope-induced virological synapse and signaling on synthetic lipid bilayers. PMID: 22433250

Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate. PMID: 25915761

The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion. PMID: 18237398

Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip. PMID: 33883222

Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope. PMID: 26085151

CCR5 structural plasticity shapes HIV-1 phenotypic properties. PMID: 30521629

Inhibitors of HIV infection via the cellular CD4 receptor. PMID: 16611063

The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site. PMID: 2016774

Characterization of V3 loop-binding protein(s) of Molt-4 and U937 cells. PMID: 7576912

Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. PMID: 11907225

Filamin-A regulates actin-dependent clustering of HIV receptors. PMID: 17572668

[Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1]. PMID: 1518160

Potent suppression of HIV-1 cell attachment by Kudzu root extract. PMID: 30236131

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HIV1 Surface protein gp120 Nanobody (SAA0894) [RVV03105]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only